Guggenheim Capital LLC Kura Oncology, Inc. Transaction History

Guggenheim Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $14,412 - $23,340	-1,200 Reduced 5.22%	21,770 $297,000
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $18,217 - $31,179	-1,701 Reduced 6.89%	22,970 $421,000
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $10,766 - $15,519	914 Added 3.85%	24,671 $397,000
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $4,252 - $6,810	348 Added 1.49%	23,757 $333,000
Q3 2021 Nov 15, 2021	SELL	$15.42 - $21.72 $8,373 - $11,793	-543 Reduced 2.27%	23,409 $438,000
Q2 2021 Aug 13, 2021	BUY	$20.85 - $29.88 $22,851 - $32,748	1,096 Added 4.8%	23,952 $499,000
Q1 2021 May 13, 2021	BUY	$24.75 - $39.14 $269,775 - $426,626	10,900 Added 91.17%	22,856 $646,000
Q4 2020 Feb 16, 2021	BUY	$29.0 - $41.62 $346,724 - $497,608	11,956 New	11,956 $390,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.